Atlas Venture Fund XI, L.P.

10% OwnerXilio Therapeutics, Inc. (XLO) · full profile →Form 4 · filed Feb 9, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$640
Net Open-Market Flow
-$640
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 8, 2024Sell(S)267$0.64$171735K
Feb 8, 2024Sell(S)733$0.64$4692.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-003031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.